Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 22, 2005

View Archived Issues

RG-108 reactivates tumor suppressor genes by reverting epigenetic mutations in cancer cells

In vitro antiangiogenic actions of pasireotide compared to octreotide

Transferrin receptor revealed as a novel cancer target

New data on the antitumor effects and safety of ZD-6474 in solid malignancies

Response to HSPPC-96 is not affected by cytokines in advanced melanoma patients

ADAM33 gene involved in embryonic airway development and determines severity of COPD

QR-333 safely reduces symptoms of diabetic peripheral neuropathy

Pegvisomant treatment benefits patients with acromegaly

Bosentan shows efficacy in stabilizing disease in patients with advanced melanoma

New phase II data supports the use of Rambazole in acne

Snapshots on pregabalin in epilepsy and neuropathic pain

Novagali Pharma completes initial clinical evaluation of proprietary oral paclitaxel

Novartis reports promising phase III data with SPP-100 for hypertension

Cytheris initiates additional phase I/II trial with recombinant interleukin-7

FDA grants full approval to Arimidex for treatment of postmenopausal breast cancer

The Immune Response Corporation reports update on HIV and MS clinical programs

Curis and Procter & Gamble collaborate on hair growth program

NeuTec Pharma to evaluate Mycograb for breast cancer

Tachykinin antagonists prepared and tested at Takeda

Celera begins phase I clinical evaluation of cathepsin S inhibitor for psoriasis

Celtic Pharma acquires worldwide rights to Xerecept

Isis begins phase II development of second-generation antisense drug for high cholesterol

Medicure receives FDA fast track designation for MC-1

Novel antidiabetic agents disclosed in recent patent literature

Pfizer receives nonapprovable letter in U.S. for COX-2 inhibitor for acute pain

UCB's antiepileptic Keppra approved in E.U.

Novartis reports phase III data and update of R&D pipeline

Anti-HEH4 antibodies claimed for bone or cartilage-related disorders

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...